Lee F Langer

Title: Lee F. Langer: Innovator in Cancer Pathway Detection

Introduction

Lee F. Langer is an accomplished inventor based in Chicago, IL. He has made significant contributions to the field of cancer research through his innovative patent. His work focuses on the detection of cellular pathway dysregulation in cancer specimens, which is crucial for advancing personalized medicine.

Latest Patents

Langer holds a patent titled "Systems and methods for detecting cellular pathway dysregulation in cancer specimens." This patent discloses systems, methods, and compositions that utilize RNA expression level information to determine cellular pathway disruption. The insights gained from this disruption can assist in identifying genetic variants that alter pathway activity, correlating these variants with disease state and progression, and identifying effective therapeutics.

Career Highlights

Lee F. Langer is currently associated with Tempus Labs, Inc., a company that focuses on leveraging technology to improve patient outcomes in cancer care. His expertise in the field has positioned him as a key player in the development of innovative solutions for cancer diagnostics.

Collaborations

Langer collaborates with talented professionals in his field, including Nike Tsiapera Beaubier and Joshua S. K. Bell. These collaborations enhance the research and development efforts at Tempus Labs, Inc., fostering an environment of innovation.

Conclusion

Lee F. Langer's contributions to cancer research through his patent and work at Tempus Labs, Inc. highlight the importance of innovation in the medical field. His efforts are paving the way for advancements in cancer diagnostics and treatment.